Google.org

Push Security specializes in cybersecurity software that aims to prevent identity-based attacks. Its browser-based agent monitors how employees create and use identities, generating unique telemetry that can be accessed through the Push platform or integrated with existing security information and event management (SIEM) systems. This allows security teams to oversee their entire identity attack surface and effectively detect and block various identity-based threats, including advanced phishing techniques. Push Security enforces preventive measures that guide employees within their browser, helping to avert potential breaches before they occur. The platform also provides clear guidance for implementing essential security controls, with automation facilitating quicker deployment. This approach enables organizations, particularly small and medium-sized enterprises, to enhance their security measures efficiently and affordably without the need for additional solutions.

Omni is a multifaceted company based in San Francisco, California, that specializes in business intelligence, cybersecurity, and cloud engineering services. Its primary offering is a unique business intelligence platform that merges the reliability of a shared data model with the flexibility of SQL, allowing users to easily access, explore, and share curated data metrics. This platform is designed to streamline the data analytics process, enabling clients to focus on deriving meaningful insights without the complications often associated with data management. Additionally, Omni operates a rentals platform that connects local businesses with community members, providing access to a variety of rental items such as bikes, surfboards, and camping equipment. This initiative enhances community engagement by making diverse products readily available for short-term use.

Blockaid is a technology company that specializes in digital security. It develops a security platform designed to safeguard users from fraud, phishing, and hacks. The company employs a range of security features, including blockchain technology, to ensure the safety and security of users' data. This enables online businesses to offer their services with confidence, knowing that their customers' data is protected.

Allara is a healthcare program focused on providing specialized virtual care for women dealing with complex chronic health conditions, particularly polycystic ovary syndrome. The platform connects patients with medical providers and registered dietitians, offering a comprehensive approach that includes diagnostic testing, prescriptions, and personalized video consultations. Allara emphasizes holistic care, integrating dietary and lifestyle changes alongside nutrition counseling to help women manage their health effectively. Through its virtual appointments, the program aims to simplify access to expert care, enabling patients to track and improve their overall medical wellbeing.

Leyden Labs is a biotechnology company focused on developing intranasal products aimed at protecting individuals from respiratory viruses. By targeting commonalities among various viral families, Leyden Labs seeks to provide broad-spectrum protection against multiple strains of viruses, including those in the influenza and coronavirus families. Unlike traditional vaccines that typically address specific variants, Leyden Labs' innovative approach allows for simultaneous protection against a range of viruses, thereby empowering individuals to safeguard their health and prevent the transmission of diseases. The company's team comprises experienced biotechnology professionals and new talent, all committed to advancing solutions that alleviate the impact of respiratory infections on global health.

Roboflow, Inc. is a software-as-a-service company focused on enhancing computer vision capabilities for software engineers. Founded in 2019 and based in Des Moines, Iowa, Roboflow offers solutions such as Roboflow Organize, which assists developers in managing image datasets and annotations, and Roboflow Pro, designed to facilitate the deployment of computer vision applications using existing engineering resources. The company's tools streamline the creation and organization of datasets, including both image and video data, and employ pre-trained models and artificial intelligence to automate the annotation process. By providing features like dataset management, image transformations, and easy integration, Roboflow enables teams to build computer vision models more efficiently, improving accuracy and reducing common errors that can hinder model performance.

Vitara Biomedical is focused on developing a therapeutic platform designed to support premature infants. The company draws inspiration from natural physiological processes to improve neonatal care, aiming to enhance the quality of life for these vulnerable newborns. By addressing the unique challenges faced by premature infants, Vitara Biomedical seeks to reduce mortality rates and associated health complications, ultimately providing a foundation for a healthier future for both infants and their families.

Metsera is a clinical-stage biopharmaceutical company dedicated to developing innovative therapies for obesity and metabolic conditions. The company focuses on advancing a variety of oral and injectable treatment options, including incretin, non-incretin, and combination therapies. These treatments are designed to address multiple therapeutic targets, positioning Metsera to meet the evolving demands of the weight loss treatment landscape. Additionally, Metsera integrates proprietary health technology tools to provide personalized care, enhancing the effectiveness of its therapeutic offerings.

PeopleOne Health specializes in providing comprehensive healthcare solutions that integrate treatment and prevention, leading to substantial cost savings for both employers and employees. By focusing on value-based primary care, the company enables employers to save up to 30% on healthcare expenses while improving employee recruitment and retention. Employees benefit from an award-winning health program at no cost, which includes access to a dedicated team of top-tier healthcare professionals. PeopleOne Health designs and implements tailored corporate wellness programs for medium and large organizations, empowering employees to manage their health risks and stay informed about wellness opportunities. The company's commitment to customer satisfaction is reflected in an impressive net promoter score exceeding 90, significantly higher than the healthcare industry average.

Scope3 operates a supply chain emissions data platform that provides accurate and comprehensive emissions data to assist companies in integrating sustainability into their business decisions. The company develops models that outline the core inputs and outputs for products and services within the supply chain, enabling organizations to design more sustainable systems. Additionally, Scope3 prepares monthly sustainability reports that offer updated emissions data, allowing businesses to swiftly adapt to external changes and recognize their efforts in reducing carbon footprints.

Mechanical Orchard is a technology company based in San Francisco that specializes in modernizing and maintaining essential business applications for large enterprises. By leveraging GenAI and advanced software engineering practices, the company focuses on updating legacy computer systems, thereby reducing risks associated with modernization. Mechanical Orchard provides cloud operations as a service, ensuring that businesses can run secure, reliable, and scalable applications. Its mission is to empower clients to remain competitive in a rapidly evolving marketplace, helping them to adapt and thrive amid technological change.

Cardurion Pharmaceuticals, LLC is a biotechnology company based in Boston, Massachusetts, established in 2017. The company specializes in developing innovative therapeutics aimed at treating heart failure and other cardiovascular diseases. Cardurion is advancing clinical programs that focus on inhibiting PDE9 and CaMKII, utilizing its knowledge of cardiovascular signaling pathways to meet significant patient needs in this area.

Hebbia Inc. is a technology company that specializes in developing AI productivity tools tailored for knowledge workers. Established in 2020 and headquartered in West Hollywood, California, Hebbia offers a unique platform designed to facilitate complex task management by transforming prompts into actionable processes completed by AI agents. The platform is utilized by professionals in finance, law, government, and pharmaceuticals, enabling them to handle extensive workflows involving millions of documents. Unlike many AI systems that operate as a black box, Hebbia's technology is transparent, allowing users to verify and collaborate effectively with the AI. It efficiently ingests both structured and unstructured data from various sources, retrieves relevant information upon request, and presents answers in a user-friendly, spreadsheet-like format, thereby supporting comprehensive workflow automation.

Santa Ana Bio is a biotechnology company focused on developing precision therapies for autoimmune and inflammatory diseases. By utilizing advanced technologies such as deep cell profiling, single-cell genomics, and multi-omics platforms, the company designs targeted biologics that aim to provide effective and personalized treatment options. Through its innovative approach, Santa Ana Bio seeks to enhance patient outcomes and improve quality of life for those affected by autoimmune conditions.

Cerevance LLC is a biotechnology company focused on developing innovative therapeutics for neurological and psychiatric disorders, including Alzheimer's disease, Parkinson's disease, and other chronic neurodegenerative conditions. Founded in 2016 and headquartered in Boston, Massachusetts, with an additional office in Cambridge, United Kingdom, the company utilizes its NETSseq platform to profile specific brain cell types, including neurons and glial cells, using a repository of over 15,000 human brain tissue samples. This platform provides detailed expression and epigenetic data, allowing Cerevance to identify promising therapeutic targets for central nervous system diseases. Through its research, the company aims to advance new medicines that can potentially address the underlying mechanisms of these debilitating conditions.

Midi Health is a virtual care clinic dedicated to addressing the health needs of women, particularly during menopause and related conditions. The clinic specializes in treating issues such as depression, gynecological cancer, and menstrual problems through a clinical platform that delivers personalized care protocols. These protocols are administered by clinicians who are trained in female midlife health. Midi Health enhances its services by utilizing specialized at-home labs, providing prescription medications, supplements, and lifestyle coaching. This comprehensive approach aims to empower women to manage the challenges they face during critical stages of their lives and careers.

Alethea is a technology company helping the Fortune 500, private companies and nonprofits protect themselves from harms stemming from disinformation. Leveraging its multi-channel machine learning platform, Artemis, Alethea detects disinformation narratives across the internet, enabling customers to proactively defend against this pervasive threat. With Artemis-powered early detection, Alethea customers can protect their reputations, key assets, physical safety and market value. The company was founded in 2019 and is woman owned.

Oula Health, Inc. specializes in maternity care services, offering both in-clinic and home-based prenatal care. Founded in 2019 and located in Brooklyn, New York, Oula aims to transform the maternity care experience by integrating obstetrics and midwifery. The company focuses on providing a personalized and evidence-based approach to pregnancy, combining modern medical practices with a compassionate understanding of human needs. Through its innovative maternity center, Oula sets a new standard for pregnancy care that emphasizes both medical expertise and personal connection.

Comanche Biopharma is a biopharmaceutical company focused on developing an investigational small interfering RNA (siRNA) medicine aimed at treating preterm preeclampsia. The company is committed to ensuring that all women and their babies have access to safe and effective therapies for life-threatening complications during pregnancy. Comanche Biopharma's mission emphasizes the importance of evidence-based and affordable solutions, enabling women to receive cost-effective treatments that address the root causes of preeclampsia.

Seismic Therapeutic is a biotechnology company focused on accelerating immunology drug development through the integration of machine learning in the biologics discovery process. Its IMPACT™ platform addresses key challenges in biologics discovery by combining structural biology, protein engineering, and translational immunology. This innovative approach aims to create optimized therapies more efficiently, ultimately benefiting patients with autoimmune diseases and disorders linked to adaptive immune system dysregulation. With a robust pipeline of biologics, Seismic Therapeutic is committed to enhancing the speed and efficacy of drug development in the field of immunology.

Signos is focused on addressing the obesity epidemic by promoting healthy habits and stabilizing glucose levels through an innovative approach that combines continuous glucose monitoring with an AI-powered application. The company's platform offers real-time insights and personalized recommendations aimed at facilitating sustainable weight loss. By utilizing a wearable device alongside its software, Signos allows users to monitor their glucose levels and visualize their metabolism, empowering them to make informed dietary choices. With a significant portion of the American population facing challenges related to weight management, Signos provides a novel solution to help individuals understand their unique physiological responses to food, ultimately supporting their journey toward a healthier lifestyle.

Scope3 operates a supply chain emissions data platform that provides accurate and comprehensive emissions data to assist companies in integrating sustainability into their business decisions. The company develops models that outline the core inputs and outputs for products and services within the supply chain, enabling organizations to design more sustainable systems. Additionally, Scope3 prepares monthly sustainability reports that offer updated emissions data, allowing businesses to swiftly adapt to external changes and recognize their efforts in reducing carbon footprints.

ROME Therapeutics, Inc. is a biotechnology company based in Cambridge, Massachusetts, focused on developing innovative therapies for cancer and autoimmune diseases. Established in 2019, the company utilizes the repeatome—a previously overlooked segment of genetic material—to create novel treatment options. By identifying multiple drug targets and advancing several discovery programs, ROME Therapeutics aims to tap into this unexplored area of biology. The organization has assembled a team of experts in oncology, immunology, virology, and machine learning to lead its research and development efforts, which are designed to provide healthcare professionals with effective new treatments for patients suffering from these conditions.

Modular is an AI software development platform aimed at simplifying the creation and deployment of artificial intelligence applications. The platform integrates various popular frameworks through common interfaces, enhancing usability and flexibility while ensuring compatibility across diverse hardware backends and cloud environments. This approach allows developers to adopt the tools seamlessly into their existing workflows without the need for extensive code modifications. By focusing on production-quality infrastructure and a straightforward user experience, Modular enables developers to save time and increase their productivity, ultimately streamlining the development process from edge to datacenter.

Deepset is a company specializing in natural language processing (NLP) solutions, focusing on leveraging the latest advancements in machine learning to create real-world applications. It is known for developing the Haystack open-source framework, which facilitates the deployment of NLP tasks, and for offering deepset Cloud, a platform designed for enterprise AI teams. Since its inception in 2018, deepset has supported numerous AI teams globally by providing reliable, open-source technology and tailored solutions. The company's software emphasizes the use of transfer learning to enhance model performance while minimizing the amount of training data required, thereby enabling users to unlock value from diverse text sources effectively.

Typeface is a generative AI application designed for enterprise content creation, facilitating the development of personalized and on-brand materials. The company offers industry-first self-service solutions that streamline the entire content lifecycle, allowing employees to generate high-quality content quickly and efficiently. By combining content velocity with brand personalization and control, Typeface enables organizations to enhance their content production capabilities, ensuring that all generated materials maintain brand authenticity while meeting the demands of speed and creativity. This innovative platform empowers users at all levels to craft captivating content effortlessly.

Warp is a developer of a Rust-based coding terminal aimed at enhancing productivity in coding and application development. Its software innovatively transforms the traditional command-line interface by dividing the terminal output into a sequence of commands, rather than presenting it as a single buffer. This approach replaces the standard character buffer with a comprehensive text editor, allowing software developers to efficiently navigate, copy, save, and share their work. Warp's terminal redefines the user experience by evolving from a single-user utility into a collaborative platform, where sessions, blocks, and environments are persistent, searchable, and easily shared via links.

Pixxel is a space data company based in Bengaluru, India, that specializes in manufacturing remote sensing satellites. Founded in 2018, the company develops a constellation of hyperspectral earth imaging satellites capable of capturing geospatial data from every location on the planet. These satellites provide globally accessible, real-time data that can be used for various applications, including climate monitoring, crop yield prediction, urban planning, and disaster response. The constellation is designed to offer global coverage every 24 hours, enabling users to detect, monitor, and predict environmental and economic phenomena. Through its advanced analytical tools, Pixxel aims to support organizations in making informed decisions based on ever-changing data.

Chroma Medicine is a genomic medicine company founded in 2021 and based in Cambridge, Massachusetts, specializing in epigenetic editing. The company is pioneering a new class of genomic therapies aimed at revolutionizing the treatment of genetically driven diseases. By utilizing epigenetics, which is the natural mechanism for gene regulation, Chroma Medicine develops programmable epigenetic editors that target specific genes and modulate chromatin conformation. This innovative approach enables healthcare providers to achieve precise control of gene expression, offering a promising therapeutic option for conditions linked to genetic anomalies.

Aera Therapeutics is a biotechnology company focused on enhancing the delivery of genetic medicines through its proprietary protein nanoparticle (PNP) platform. This innovative platform utilizes endogenous human proteins to create capsid-like structures that can effectively package and transfer nucleic acid cargo. By addressing the limitations of current delivery technologies, Aera aims to extend the application of genetic medicines across various tissues and disease areas, ultimately benefiting a wider patient population. In addition to its PNP platform, Aera has developed a therapeutic enzyme platform that features novel, compact, and programmable gene-editing enzymes, further advancing its mission to transform the field of genetic medicine.

Cerevance LLC is a biotechnology company focused on developing innovative therapeutics for neurological and psychiatric disorders, including Alzheimer's disease, Parkinson's disease, and other chronic neurodegenerative conditions. Founded in 2016 and headquartered in Boston, Massachusetts, with an additional office in Cambridge, United Kingdom, the company utilizes its NETSseq platform to profile specific brain cell types, including neurons and glial cells, using a repository of over 15,000 human brain tissue samples. This platform provides detailed expression and epigenetic data, allowing Cerevance to identify promising therapeutic targets for central nervous system diseases. Through its research, the company aims to advance new medicines that can potentially address the underlying mechanisms of these debilitating conditions.

Pangea is a developer of security APIs that offers a comprehensive portfolio of security services tailored for application builders. The company provides a single platform that simplifies the integration of security into cloud and mobile applications. Pangea's services are designed to be globally accessible while maintaining regional intelligence, making them suitable for diverse markets. Available on major cloud platforms such as AWS and GCP, Pangea enables clients—including app developers, SaaS providers, and security operations teams—to efficiently create secure and compliant user experiences. The company aims to make security accessible to all developers, eliminating the need for extensive security expertise.

Dandelion Energy, Inc. is a Palo Alto, California-based company founded in 2017 that specializes in affordable geothermal heating and cooling solutions. The company replaces traditional air conditioning and heating systems with an innovative home geothermal system that utilizes a powerful heat pump and underground pipes to transfer heat between the earth and the residence. This system is designed to harness thermal energy from below the earth's surface to regulate indoor temperatures and provide hot water, allowing homeowners to transition from conventional heating fuels to a more sustainable geothermal alternative. Dandelion Energy is committed to making renewable heating and cooling accessible and cost-effective for homeowners.

Landis is an online real estate platform founded in 2018 and headquartered in New York, NY, that focuses on helping renters become homeowners. The company allows clients to choose their dream home, rent it, and purchase it within the first twelve months. In addition to facilitating this transition, Landis provides tools and incentives designed to assist clients in improving their credit scores and accumulating down payment savings. With a commitment to transparency and simplicity, Landis aims to create a seamless process for renters to transition to homeownership. The company also specializes in commercial real estate technology and residential offerings.

Altana Technologies operates a global supply chain platform that transforms public and non-public data into an intelligent map of the global supply chain. The platform, known as Altana Atlas, connects enterprises, governments, and logistics providers, facilitating collaboration and trust within business networks. It offers trade data management services by integrating internal and external data to provide clean data sets and a real-time view of transactions, ownership, movements, and risks across the global trade network. By leveraging machine learning, Altana enables organizations in both the public and private sectors to enhance the safety, efficiency, and profitability of trade, while promoting a more resilient, secure, inclusive, and sustainable approach to globalization.

Adda247 is an edtech platform based in Gurugram, India, specializing in the preparation for government examinations. Founded in 2010, the company provides a comprehensive learning ecosystem that includes online courses, study materials, and test series for various competitive exams. As a subsidiary of Metis Eduventures Private Limited, Adda247 aims to empower students with the resources needed to succeed in their academic and career pursuits in the public sector. The platform leverages technology to deliver accessible and effective educational solutions, making it a prominent player in the Indian education landscape.

Flatfile Inc. is a company that specializes in data onboarding solutions, enabling developers to efficiently validate, map, and import CSV data from various web applications. Founded in 2018 and based in Denver, Colorado, Flatfile offers a platform that integrates seamlessly with software applications, allowing users to upload data through formats such as CSV, XLS, or TSV. Its key products include Portal, which provides an import button embedded via a JavaScript snippet, and Concierge, which creates secure collaborative workspaces for organizations to manage complex data ingestion challenges. The platform is designed to enhance developer productivity, reduce costs, and improve data quality by learning to identify and clean incoming data over time. Numerous companies, including AstraZeneca and Square, utilize Flatfile’s API-first platform to streamline their data import processes.

Sardine is a financial technology company that specializes in providing a risk and fraud infrastructure tailored for the online economy. It has developed a device intelligence platform that leverages artificial intelligence and advanced risk engine software. This platform enhances fraud detection while minimizing sign-up friction by analyzing multiple real-time data points, including device information, browser details, and behavioral biometrics. By integrating this technology, Sardine enables businesses to establish a robust risk and fraud management framework, ultimately reducing costs within the fintech ecosystem.

SpinLaunch Inc. is a spaceflight technology development company based in Long Beach, California, founded in 2014. The company is focused on creating an innovative launch system that utilizes a large mass accelerator, or centrifuge, to propel payloads into space without the use of chemical propellants. This kinetic space launch system is designed to enable on-demand launches of small satellites in various weather conditions. By spinning the payload in a vacuum to minimize friction, SpinLaunch aims to achieve speeds of approximately 3,000 miles per hour. This method allows for a more cost-effective and sustainable approach to space travel, as the system can either launch payloads directly into space or assist them with supplemental rockets to exit Earth's atmosphere.

Vitara Biomedical is focused on developing a therapeutic platform designed to support premature infants. The company draws inspiration from natural physiological processes to improve neonatal care, aiming to enhance the quality of life for these vulnerable newborns. By addressing the unique challenges faced by premature infants, Vitara Biomedical seeks to reduce mortality rates and associated health complications, ultimately providing a foundation for a healthier future for both infants and their families.

Isovalent, Inc. specializes in developing software solutions for enterprises to connect, monitor, and secure workloads in cloud-native environments. The company's flagship product, Cilium, leverages eBPF to enhance networking, security, and observability for Kubernetes deployments across both cloud and on-premises infrastructures. Isovalent offers Cilium Enterprise, which focuses on security automation, compliance, and integration with legacy systems, along with open-source tools that facilitate network connectivity, threat detection, and security compliance monitoring. Founded by the creators of Cilium and eBPF, Isovalent serves a diverse clientele, including major organizations like Adobe, AWS, and Google. The company was established in 2016 and has its headquarters in Cupertino, California, with an additional office in Zurich, Switzerland.

Lori Systems is a logistics platform based in Nairobi, Kenya, that connects transporters with cargo owners across Africa. Founded in 2016, the company also has offices in Mombasa, Uganda, and Lagos. Lori addresses a significant challenge in the African logistics sector, where up to 75% of product costs can be attributed to logistics, compared to only 6% in the United States. The platform provides a tech-enabled and operations-driven marketplace that enhances transparency, flexibility, reliability, and cost efficiency, achieving savings of over 18% for users. It offers real-time tracking of cargo, automated documentation, and streamlined payment processes, facilitating smoother goods transportation across the continent. Since its product launch in May 2017, Lori has experienced rapid growth, with a compounded monthly increase of 30%. The demand for its services continues to rise, supported by recent investments from prominent institutional and strategic investors. The company has also received recognition, including winning Techcrunch Battlefield Africa.

Merlin Labs is an innovative company focused on creating autonomous flight technology for advanced air travel, primarily utilizing fixed-wing aircraft. Founded in 2018 and headquartered in Boston, Massachusetts, the company develops a sophisticated aircraft autonomy system that employs artificial intelligence and machine learning, akin to the technology used in driverless cars. This system aims to facilitate the pilotless transportation of goods and eventually people, establishing a new infrastructure for aerial mobility.

Courier provides a notification management platform that allows developers to effectively route user notifications across various communication channels, such as email, SMS, and messaging apps. By utilizing an API, the platform intelligently determines the optimal channel for delivering messages based on user engagement and online status. This capability enables businesses to craft a single message that can be reused across multiple channels or customized for specific platforms, ensuring timely and relevant communication with users, business partners, and external stakeholders. With a commitment to customer success, Courier has evolved alongside technological advancements while maintaining stable management practices and long-term relationships with its clients.

Sesame, Inc., also known as SesameCare, is a New York-based company founded in 2018 that specializes in providing a platform for booking medical appointments and consultations. The company distinguishes itself by offering affordable healthcare options, enabling Americans to access quality medical services at significantly reduced prices compared to traditional providers. By utilizing an AI-enabled marketplace, Sesame eliminates the need for insurance, fostering competition among healthcare providers based on quality, accessibility, and pricing. Additionally, Sesame serves as the official telehealth partner of Costco, further enhancing its reach and service offerings in the healthcare sector.

Wonder is a technology company that specializes in gaming and food delivery services. It offers an all-in-one gaming platform for Android mobile devices, enabling users to play, stream, and share games across various devices. Additionally, Wonder operates a food delivery service using trucks that function as mobile restaurants. Customers order food through a mobile app, and the Wonder trucks drive to a location near the user's home to prepare and deliver fresh meals on-site.

Nava is a health insurance brokerage based in New York, New York, dedicated to providing high-quality, affordable healthcare solutions to employers and their employees. The company offers a range of services that include healthcare tools, year-round employee advocacy, and continuous evaluation of healthcare plans. By leveraging these resources, Nava empowers clients to deliver essential benefits while simultaneously reducing overall plan costs. Its innovative approach aims to transform the employee benefits landscape through enhanced access and advocacy in healthcare.

FarmWise, established in 2016 and headquartered in San Francisco, specializes in developing and manufacturing robotic machinery for agriculture. The company's primary product is a mechanical weeder, designed to efficiently remove weeds and thin crops, thereby enhancing agricultural productivity. FarmWise also provides comprehensive training and support to ensure the effective use of its technology.

Mirvie is a biotech company focused on developing non-invasive tests aimed at improving maternal-fetal health. Founded in 2018 and based in South San Francisco, California, Mirvie offers a medical diagnostic platform that provides actionable insights for mothers and families throughout their pregnancy journey. The company's innovative predictive tests help medical practitioners identify at-risk pregnancies, allowing for timely interventions and enhanced management of pregnancy-related concerns. By prioritizing safety and health, Mirvie seeks to empower families with the information necessary for better pregnancy outcomes.

Invetx, Inc. is a biotechnology company focused on developing protein-based therapeutics for animal health care and veterinary medicine. Based in Boston, Massachusetts, Invetx's team comprises veterinary scientists and clinicians dedicated to discovering and creating biotherapeutics for both pets and farm animals. The company aims to enhance health outcomes in the animal health industry by leveraging biopharma technologies, supported by a network of experts in animal and human health. Through its innovative platform, Invetx is committed to advancing a portfolio of therapies and technologies designed to improve animal care and well-being.

Aspen Neuroscience, Inc. is a biotechnology company focused on developing induced pluripotent stem cells (iPSCs) to create patient-specific therapies for neurological conditions, particularly Parkinson's disease. Founded in 2018 and based in San Diego, California, the company is advancing its pipeline of products, which includes ANPD001, an autologous neuron replacement therapy for sporadic Parkinson's disease, and ANPD002, a gene-edited autologous neuron replacement therapy targeting familial forms of the disease. Aspen Neuroscience employs innovative genomic approaches in conjunction with stem cell biology to address diseases with significant unmet medical needs, aiming to provide restorative cell therapies that can modify the progression of Parkinson's disease and potentially extend to other affected organs.

OMass Therapeutics Limited is a biotechnology company based in Oxford, United Kingdom, established in 2016. The company specializes in drug discovery, utilizing structural mass spectrometry technology to develop innovative therapeutics aimed at difficult disease targets. Its platform allows clients to access native mass spectrometry without the need for sophisticated instrumentation or in-house expertise. This capability enables the study of complex protein assemblies and their interactions with other biological molecules, facilitating the development of drugs and biotherapeutics. OMass Therapeutics aims to provide a dynamic and collaborative environment for biotechnology and pharmaceutical clients to address challenging drug targets effectively.

Celsius Therapeutics is a biotechnology company focused on developing precision medicines for patients with cancer and autoimmune diseases. Founded in 2018 and based in Cambridge, Massachusetts, the company employs a team of scientists, technologists, computational biologists, clinicians, and drug hunters. Utilizing single-cell genomic analysis and machine learning techniques, Celsius Therapeutics aims to discover and create innovative therapies that can lead to significant improvements in patient outcomes. The company's research efforts are centered on identifying new drug candidates that address unmet medical needs in the therapeutic landscape.

Spotlight Therapeutics, Inc. specializes in the development of gene editing therapeutics designed to target specific cell populations directly within the body. Established in 2017 and based in Hayward, California, the company leverages a biotechnology platform that utilizes CRISPR nuclease effectors for in vivo gene editing. Its innovative approach aims to create next-generation programmable nucleases that enhance treatment options for a variety of conditions. Spotlight Therapeutics is focused on multiple therapeutic areas, including immuno-oncology, ophthalmology, and hematology, and is developing programs to address previously undruggable intracellular gene targets as well as specific monogenic disease targets related to the eye. This targeted gene editing strategy seeks to overcome the challenges associated with traditional delivery methods, thereby providing healthcare providers with improved tools for patient treatment.

Nothing is a consumer electronics company that designs and manufactures smartphones, earbuds, and other connected devices. It aims to remove barriers between people and technology by focusing on product integration and user experience. The company offers mobile devices and personalized noise-cancellation earbuds featuring wireless charging, water resistance, and dual connectivity. Through its innovative approach, Nothing seeks to create a seamless digital ecosystem that combines hardware and software, providing customers with reliable and durable technology at affordable prices.

Redpanda Data is a company that provides a modern streaming data platform designed to handle large data streams effectively. Its platform allows users to record both real-time and historical enterprise data, making it a valuable tool for organizations that require efficient data management. Redpanda's architecture features a compatible application programming interface and is deployable as a single binary, which simplifies the deployment process. Additionally, it includes a built-in schema registry and operates without external dependencies, enhancing performance and reliability for developers. This combination of features enables enterprises to maintain their software stacks while improving data processing capabilities.

Censys, Inc. specializes in internet scanning and asset identification solutions, offering a platform that enables organizations to gain a real-time view of global networks and devices. Founded in 2017 and based in Ann Arbor, Michigan, Censys provides tools for attack surface management, allowing users to discover unknown assets, monitor remote workforces, and identify threat actors. Its internet intelligence platform is designed for threat hunting and exposure management, creating a comprehensive dataset that enhances visibility into vulnerabilities and internet-exposed infrastructure. This enables businesses to efficiently locate and manage the devices, networks, and infrastructure that are critical to their operations.

Leyden Labs is a biotechnology company focused on developing intranasal products aimed at protecting individuals from respiratory viruses. By targeting commonalities among various viral families, Leyden Labs seeks to provide broad-spectrum protection against multiple strains of viruses, including those in the influenza and coronavirus families. Unlike traditional vaccines that typically address specific variants, Leyden Labs' innovative approach allows for simultaneous protection against a range of viruses, thereby empowering individuals to safeguard their health and prevent the transmission of diseases. The company's team comprises experienced biotechnology professionals and new talent, all committed to advancing solutions that alleviate the impact of respiratory infections on global health.

Sibros specializes in software-defined vehicle technology through its Deep Connected Platform™, which integrates real-time data collection, software configuration management, remote updates, and diagnostic commands. This platform adheres to essential automotive safety, security, and data privacy standards, making it adaptable for various vehicle architectures, including legacy gas and diesel models, next-generation battery electric vehicles, fuel cells, motorcycles, buses, commercial trucks, and heavy machinery. The company's innovative technology, developed in Silicon Valley, allows original equipment manufacturers (OEMs) to enhance customer experiences, achieve cost efficiencies, and explore new revenue models throughout the mobility product life cycle. Sibros' solutions enable automakers to manage their vehicle software inventory, configurations, and updates while providing insights through extensive vehicle analytics and remote command capabilities.

InstaDeep Ltd is a company that specializes in developing artificial intelligence-based decision-making systems for the enterprise sector. Founded in 2014 and headquartered in London, the company also has offices in Paris, Tunis, Nairobi, and Lagos. InstaDeep's platform is designed to enhance talent retention and training while providing a range of AI programs. These include optimized pattern recognition, GPU-accelerated insights, self-learning systems, machine learning, and predictive analytics. By utilizing these technologies, InstaDeep enables businesses to improve efficiencies in manufacturing, logistics, mobility, and energy, ultimately leading to increased return on investments.

Mill is a company focused on addressing food waste, a significant environmental challenge. It offers innovative kitchen bins that dry, shrink, and eliminate odors from leftover food, transforming waste into a compost-like material. These digitally connected bins can be rented, allowing users to efficiently manage their kitchen waste overnight. Additionally, Mill facilitates the shipping of the processed material to facilities that convert it into animal feed, thereby promoting a sustainable waste management system. Through its products and services, Mill aims to contribute to a healthier environment by providing practical solutions for reducing food waste at home.

Found is dedicated to improving people’s overall wellbeing by making evidence-based weight loss accessible and affordable. The company was founded in 2019 and is headquartered in San Francisco, California, United States.

Synthesia Ltd. is a London-based company that specializes in an artificial intelligence-driven video production platform. Founded in 2017, the company offers a service that transforms text into professional-quality videos featuring customizable avatars and voiceovers in over 140 languages. Its innovative video synthesis technology allows users to create high-end videos for various applications, including personalized advertising, corporate communications, e-learning, and marketing. By synchronizing lip movements with new dialogue tracks, the platform facilitates the translation of video content into different languages, thereby enhancing distribution channels. Users can quickly create, edit, and share studio-quality videos directly in their browser, utilizing fully cloneable AI video templates to streamline production and meet diverse content needs.

Universe is a mobile application that enables users to create websites, online shops, and portfolios. The platform provides essential tools, including a payment block for processing transactions and an order management system to streamline financial operations. By facilitating the building of digital presence and supporting e-commerce activities, Universe aims to simplify the online selling experience for individuals and businesses alike.

Upbound, Inc. is a technology company that specializes in multi-cloud solutions, enabling organizations to manage and optimize their operations across various cloud environments as a cohesive unit. Founded in 2017 and based in Seattle, Washington, Upbound's platform is powered by Crossplane, allowing platform engineers to create, deploy, and operate internal developer platforms with enhanced control and self-service capabilities. The company provides tools for automation, cost optimization, capacity overflow, failover, and policy enforcement, helping organizations to streamline their multi-cloud deployments. Additionally, Upbound offers Universal Crossplane (UXP), which includes security features, support, and a range of official providers, further enhancing the flexibility and efficiency of cloud management for its users.

Ankyra is a biotechnology company focused on developing anchored immunotherapy for cancer treatment. The company addresses the limitations of traditional cytokine therapies, which are often restricted due to widespread immune activation and associated toxicity. Ankyra's innovative approach involves the use of its Anchored Immunotherapy Platform to create ANK-101, a stable complex of a modified IL-12 cytokine and aluminum hydroxide, an FDA-approved adjuvant. This combination allows for targeted intratumoral delivery, enhancing the localized retention and activity of IL-12 while reducing systemic side effects. By optimizing the therapeutic potential of anchored immunotherapy, Ankyra aims to improve treatment outcomes for cancer patients, offering a safer and more effective alternative to conventional therapies.

Infinitus Systems is an AI healthcare company focused on automating phone-based processes to enhance efficiency within the healthcare ecosystem. By streamlining tedious and time-consuming communication tasks, Infinitus aims to improve access to therapy, adherence, and affordability for patients. The company's innovative tool allows users to submit call requests easily, track updates, and receive notifications upon task completion. Infinitus Systems has raised $51.4 million in funding from prominent investors, including Kleiner Perkins, Coatue, and Google Ventures. Through its automation solutions, the company seeks to reduce the complexity and costs associated with back-office administration in the healthcare sector.

StrongDM, Inc. is a technology company based in Burlingame, California, founded in 2015. The company offers a platform designed to manage and audit access to various databases and servers for employees, vendors, and cloud-based tools. Its services enable organizations to efficiently create and remove users, manage permissions, and ensure proper data handling. StrongDM's platform simplifies the process of controlling access across multiple systems, enhancing security and compliance. In 2016, the company gained recognition as the Audience Favorite at the Strata+Hadoop World conference, highlighting its impact in the data management sector.

ROME Therapeutics, Inc. is a biotechnology company based in Cambridge, Massachusetts, focused on developing innovative therapies for cancer and autoimmune diseases. Established in 2019, the company utilizes the repeatome—a previously overlooked segment of genetic material—to create novel treatment options. By identifying multiple drug targets and advancing several discovery programs, ROME Therapeutics aims to tap into this unexplored area of biology. The organization has assembled a team of experts in oncology, immunology, virology, and machine learning to lead its research and development efforts, which are designed to provide healthcare professionals with effective new treatments for patients suffering from these conditions.

Ultromics Limited, founded in 2017 and based in Oxford, United Kingdom, specializes in developing advanced echocardiography software aimed at enhancing the diagnosis of coronary heart disease. The company leverages artificial intelligence to create diagnostic tools that significantly improve the accuracy of echocardiography, with reported enhancements exceeding 90%. Ultromics' technology focuses on analyzing complex data from electrocardiograms, enabling healthcare providers to make informed decisions in diagnosing coronary artery disease. By providing innovative solutions for cardiologists, Ultromics aims to transform cardiovascular diagnostics and improve patient outcomes.

Sonoma Biotherapeutics develops adoptive Treg cell therapies aimed at treating autoimmune and degenerative diseases. The company employs advanced genome editing and target-specific cell therapy to create therapeutic solutions that promote self-tolerance and mitigate harmful inflammatory responses associated with conditions such as rheumatoid arthritis, inflammatory bowel disease, multiple sclerosis, amyotrophic lateral sclerosis, and Alzheimer's disease. Founded in 2019 and headquartered in South San Francisco, California, with an additional office in Seattle, Washington, Sonoma Biotherapeutics combines expertise in Treg biology and proprietary methodologies to advance its therapeutic platform, focusing on developing disease-modifying and potentially curative treatments.

Prime Medicine is a biotechnology company focused on developing genetic therapies using its proprietary Prime Editing technology. This next-generation gene editing method allows for precise "search and replace" modifications in the genome, aiming to restore normal genetic function and address the underlying causes of various diseases. By targeting a broad spectrum of conditions with significant unmet medical needs, Prime Medicine seeks to revolutionize the field of genetic medicine through effective and efficient therapeutic solutions.

Physna LLC, founded in 2015 and based in Cincinnati, Ohio, specializes in geometric deep-learning and 3D search technology. The company has developed a software platform that analyzes, compares, and codifies 3D models, facilitating quality control and automated inspection in various industries, including manufacturing, aerospace, automotive, and consumer goods. Physna also owns Thangs.com, a rapidly growing 3D community and search engine. By transforming 3D files into a structured format that software applications can understand, Physna aims to bridge the gap between physical objects and digital code. This innovation enables broader access to 3D design and analysis, fostering advancements in product design, 3D printing, augmented and virtual reality, and other fields, thus supporting increased efficiency and productivity in manufacturing.

Brightline, Inc. is a provider of pediatric behavioral health care services, established in 2019 and headquartered in Palo Alto, California. The company offers a range of services including behavior therapy, psychiatry and medication support, speech-language therapy, and occupational therapy. Brightline operates as a technology-enabled behavioral health home, utilizing innovative technology and virtual services to deliver integrated care. Its collaborative care team focuses on supporting children throughout their developmental stages and addressing the needs of their families. Brightline was previously known as Emilio Health, Inc. and rebranded in May 2020.

Favor is a direct-to-consumer service for women and people who menstruate, that’s on a mission to make healthcare more accessible by building a digital health platform that closes racial, gender and socioeconomic gaps in our healthcare system. Favor is the easiest way for women and people who menstruate to address their sexual health and overall wellbeing, regardless of where they live or if they’re covered by health insurance–making Favor an affordable, accessible telehealth provider.

PostHog is an open-source product analytics platform designed for developers, founded in 2020 and based in San Francisco, California. The platform provides a comprehensive suite of tools that includes product analytics, session recording, funnels, feature flags, and experimentation, all integrated into a single solution. By automating event tracking and user data collection, PostHog enables engineers to understand product usage and user behavior more effectively. This functionality allows development teams to create applications that are better tailored to their users' needs.

Merlin Labs is an innovative company focused on creating autonomous flight technology for advanced air travel, primarily utilizing fixed-wing aircraft. Founded in 2018 and headquartered in Boston, Massachusetts, the company develops a sophisticated aircraft autonomy system that employs artificial intelligence and machine learning, akin to the technology used in driverless cars. This system aims to facilitate the pilotless transportation of goods and eventually people, establishing a new infrastructure for aerial mobility.

Overture Life, Inc. is a biotechnology company established in 2017 and headquartered in New York, New York. The company specializes in developing robotic technology and medical devices aimed at automating the in vitro fertilization (IVF) process. Overture Life's innovations include novel embryo testing methodologies and automated cryopreservation services, which help fertility clinics identify viable embryos prior to implantation. By streamlining the IVF process, Overture Life aims to make artificial insemination more accessible, reduce costs, optimize resource use, and improve success rates for practitioners and patients alike.

OneNav specializes in developing a mobile positioning system tailored for smartphones, wearables, and Internet of Things (IoT) tracking devices. The company's innovative system leverages the modernized L5 signaling band from navigation satellite constellations, enhancing the accuracy and reliability of position data. By incorporating artificial intelligence, OneNav provides clients with upgraded, data-rich signals that support various tracking applications, ensuring precise location services across multiple platforms.

Smol is a homecare startup that specializes in delivering eco-friendly laundry capsules and dishwasher tablets directly to consumers’ homes through a subscription service. The products are designed to fit through letterboxes, making them convenient and accessible. Smol's offerings are made from recycled materials and are water-soluble, ensuring effective cleaning while minimizing environmental impact. The company emphasizes its commitment to sustainability by using no animal testing or animal-derived ingredients, making its products suitable for vegans. By providing an affordable alternative to leading brands, Smol aims to revolutionize the household cleaning market with its eco-conscious approach.

Headway is a digital health company specializing in mental healthcare. It operates a virtual network of licensed therapists who accept insurance and offer video or in-person sessions booked online, making mental health services more accessible and affordable. Additionally, Headway supports mental health providers in expanding their practices and helps individuals save on mental health sessions.

Affinia Therapeutics Inc. is focused on developing gene therapies for various diseases, particularly those affecting the muscles and central nervous system. The company specializes in creating adeno-associated virus (AAV) vectors, leveraging advanced techniques in synthetic and systems biology, as well as high-throughput screening and tissue and single-cell resolution. Founded in 2019 and based in Waltham, Massachusetts, Affinia aims to address significant unmet medical needs by providing rationally designed gene therapies with improved properties. The company's innovative approach seeks to offer effective treatments for devastating conditions that currently lack adequate therapeutic options.

AWB BioTech uses data from preclinical and clinical studies to guide a drug’s effect on patients.

Outlier is an online education platform that offers intro-level college courses online at a relatively affordable price. Their courses employ engaging content and cutting-edge educational technology to create an immersive, student-friendly learning experience. Outlier is reimagining higher education as a resource that is accessible, equitable, and affordable for everyone.

Ventus Therapeutics is a biopharmaceutical company focused on discovering and developing novel small molecule medicines aimed at treating autoimmune diseases, inflammatory diseases, and cancer by targeting the innate immune system. The company employs a structural immunology platform that provides deep insights into the mechanisms and molecular structures involved in immune responses. This platform integrates proprietary protein engineering capabilities with advanced rational and structure-based drug design tools, allowing for precise targeting of the innate immune system. Ventus is actively building a pipeline of drug programs that address critical targets within this system, particularly proteins involved in inflammasome and nucleic acid-sensing signaling pathways, thereby enabling the treatment of both acute and chronic inflammatory and immune-related conditions.

Snorkel AI, Inc. is a company that develops a comprehensive machine-learning platform designed to facilitate the creation, management, and monitoring of AI applications. Its primary offering, Snorkel Flow, allows users to programmatically label and augment training data, manage and integrate various datasets, and deploy machine learning models, while also providing tools for data analysis and monitoring. The platform is particularly effective in extracting structured information from complex documents and forms, as well as ranking content based on relevance. Founded in 2016 and based in Palo Alto, California, Snorkel AI serves a diverse range of industries, including finance, government, telecommunications, insurance, healthcare, and e-commerce. The technology was developed at Stanford AI Lab and employs innovative methods such as weak supervision to enhance data preparation, thereby streamlining the AI development process for enterprises.

Lightmatter, Inc., established in 2017 and headquartered in Boston, Massachusetts, specializes in developing AI hardware using integrated optical technology. The company's core product is a silicon chip that processes data using light signals instead of electrical signals, aiming to significantly accelerate AI computations. Lightmatter targets sectors such as artificial intelligence, cloud computing, and telecommunications, with a focus on improving efficiency and reducing power consumption in critical operations like image recognition and natural language processing.

Genesis Global Technology Limited specializes in developing custom software and solutions tailored for the capital markets. Founded in 2015 and headquartered in London, with an additional office in New York, the company provides a range of platforms designed to enhance trading and operational efficiency. Its offerings include an automated quoting system for managing requests for quotes, an order execution management system, and a trade allocation manager that facilitates various trading processes. Additionally, Genesis Global offers tools for data management and reconciliation, such as a short/long code manager and a matcher. The company is led by a team of industry veterans with substantial experience in trading technologies across multiple asset classes, aiming to deliver innovative solutions that align with the evolving needs of clients in the financial sector.

Dandelion Energy, Inc. is a Palo Alto, California-based company founded in 2017 that specializes in affordable geothermal heating and cooling solutions. The company replaces traditional air conditioning and heating systems with an innovative home geothermal system that utilizes a powerful heat pump and underground pipes to transfer heat between the earth and the residence. This system is designed to harness thermal energy from below the earth's surface to regulate indoor temperatures and provide hot water, allowing homeowners to transition from conventional heating fuels to a more sustainable geothermal alternative. Dandelion Energy is committed to making renewable heating and cooling accessible and cost-effective for homeowners.

Verve Therapeutics, Inc. is a genetic medicines company focused on innovative treatments for cardiovascular disease through gene editing. Founded in 2018 and based in Cambridge, Massachusetts, with a research facility in Philadelphia, the company aims to shift the management of cardiovascular conditions from chronic treatments to single-course gene editing therapies. Its initial programs concentrate on the PCSK9 and ANGPTL3 genes, which are known to significantly impact blood lipid levels, a major factor in cardiovascular disease. Verve Therapeutics collaborates with partners such as Beam Therapeutics and Verily to enhance its gene editing delivery technologies. The company is staffed by a team of experts in cardiovascular medicine, human genetics, and drug development, positioning itself to address the challenges of cardiovascular health effectively.

Multiverse is a technology startup that aims to provide an alternative to traditional university education by focusing on career-oriented apprenticeships. The company develops an EdTech platform designed to match young talent with professional services and digital roles, facilitating applied learning throughout their apprenticeship journeys. This approach not only equips individuals with essential skills but also helps them build social capital and establish strong professional networks. By prioritizing practical experience, Multiverse seeks to empower young people in creating fulfilling careers, thus serving as a viable alternative to conventional academic paths and uninspiring corporate training programs.

EQRx, Inc. is a biotechnology company based in Cambridge, Massachusetts, focused on transforming the drug discovery and delivery process to address the rising costs of medicines. Founded in 2019, EQRx aims to provide a market-based solution by leveraging advances in science and technology while collaborating with various healthcare stakeholders. The company has over ten programs in its pipeline targeting oncology and immune-inflammatory conditions, which include clinical and preclinical stages, as well as drug engineering initiatives. Among its key programs are Aumolertinib, Lerociclib, Sugemalimab, and Nofazinlimab. Through its innovative approach, EQRx seeks to develop high-quality, patent-protected medicines more efficiently and cost-effectively than traditional pharmaceutical methods.

LifeMine Therapeutics, Inc. is a biotechnology company focused on discovering new drug modalities from eukaryotic microbes, particularly fungi. Founded in 2016 and headquartered in Cambridge, Massachusetts, with an additional office in New York, the company employs an integrated platform that combines genomics, artificial intelligence, and synthetic biology. This innovative Avatar-Rx platform utilizes high-throughput microbiology, data science, machine learning, genome engineering, and automation to explore the fungal biosphere for novel genetically encoded molecules with specific biological functions. By integrating chemoinformatic-assisted drug optimization and advanced chemical synthesis with biotransformation, LifeMine Therapeutics aims to advance a pipeline of new medicines into development.

AMP Robotics Corporation specializes in designing and manufacturing robotic systems for material recovery facilities and recycling operations, focusing on automating the identification, sorting, and processing of complex waste streams. The company's flagship product, AMP Cortex, utilizes advanced robotics and computer vision technology to efficiently pick and sort recyclable materials, significantly lowering sorting costs. Additionally, AMP Neuron, a software solution, captures and analyzes material data to identify features in a manner similar to human perception. By leveraging artificial intelligence and machine learning, AMP Robotics enhances recycling processes for various waste types, including municipal solid waste and e-waste. The modular design of its systems allows for easy integration into existing infrastructure, minimizing disruption and capital investment. Founded in 2014 and headquartered in Louisville, Colorado, AMP Robotics has formed strategic partnerships to further its mission of improving recycling rates and economic recovery of recyclables.

Vercel Inc., established in 2015 and based in Walnut, California, specializes in developing a cloud platform for on-demand deployment of frontend applications. The company offers automated deployment solutions from pull requests via GitHub and Bitbucket, as well as merge requests through GitLab. Vercel's platform is designed to facilitate the development, previewing, and shipping of Jamstack sites, enabling efficient delivery of web pages through content delivery networks.

Locanabio, Inc. is a biotechnology company based in San Diego, California, founded in 2016. It specializes in developing RNA-targeted gene therapies aimed at treating a range of underserved diseases, particularly in the areas of neuromuscular, neurodegenerative, and retinal conditions. The company's innovative platform focuses on modifying disease-causing RNA, allowing for the identification and correction of specific RNA sequences associated with rare genetic disorders. This approach distinguishes Locanabio's therapies from traditional DNA-targeted methods, offering a unique solution for patients with severe and challenging health issues. The company, which rebranded from Locana, Inc. in July 2020, is dedicated to advancing therapeutic candidates that address significant medical needs.

Hodinkee is a New York-based company established in 2008, operating an online magazine dedicated to reviewing, critiquing, and reporting on watches. It also runs pop-up shops and an e-boutique for selling vintage watches, straps, menswear accessories like watch pockets and travel rolls, and luxury goods such as wristwatches, knit ties, pocket squares, and travel pouches. Hodinkee's platform offers a trusted retail outlet, HODINKEE Shop, alongside industry news, creative storytelling, a podcast, and a bi-annual publication, aiming to provide an approachable, authentic, and honest experience for luxury product enthusiasts.

Resilience, established in 2020 and headquartered in La Jolla, California, is a biopharmaceutical manufacturing and technology company. It specializes in providing end-to-end manufacturing and development solutions for complex medicines, including biologics, vaccines, nucleic acids, and cell and gene therapies. Resilience invests in developing new manufacturing technologies to ensure rapid, safe, and scalable production, thereby enhancing patient access to these treatments. The company partners with biopharmaceutical companies to focus on breakthrough discoveries while Resilience manages the manufacturing process, safeguarding supply chains against future disruptions.

Factory OS, Inc. designs, manufactures, and sells modular re-locatable apartment buildings and residential homes, specializing in off-site construction. Established in 2017 and headquartered in Vallejo, California, the company offers a wide range of modular solutions, including multi-family residential homes, prefabricated townhouses, modular apartments, and various commercial structures such as office buildings and retail locations. Factory OS employs an integrated and tech-enabled approach to streamline the housing development process, focusing on reducing waste, controlling energy consumption, and enhancing building efficiency. The company is committed to innovation through an active research and development program that incorporates advancements in design, technology, and construction methods.

Invivyd is a biopharmaceutical company committed to developing antibody-based therapies aimed at providing protection against serious viral infectious diseases. The company focuses on creating solutions that go beyond naturally occurring immunity, particularly in response to viral threats with pandemic potential, starting with SARS-CoV-2. Its product pipeline includes ADG20, which is designed for the treatment and prevention of COVID-19, and VYD222, a monoclonal antibody engineered for enhanced potency and broad coverage. By prioritizing rapid and enduring therapeutic options, Invivyd aims to safeguard vulnerable populations from the severe impacts of circulating viral infections.